<- Go Home

RPG Life Sciences Limited

RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmintics, anti-convulsant, anti-spasmodic, etc. It also provides generics for immunosuppressant therapy; and domestic and international finished dosage formulations for various therapies, which include nephrology, rheumatology, oncology, gastroenterology, cardiology, orthopedics, nutritional, diabetology, respiratory, neuropsychiatry, urology, vitamins and minerals, gastrointestinal, pain management, anti-diabetic, gynecology and pediatrics, cardiovascular, pediatrics, neurology, anti-dengue, dermatology, etc. The company was formerly known as RPG Pharmaceuticals Limited and changed its name to RPG Life Sciences Limited in February 2008. RPG Life Sciences Limited was founded in 1968 and is headquartered in Mumbai, India. RPG Life Sciences Limited is a subsidiary of Nucleus Life Trust.

Market Cap

INR 47.4B

Volume

22.0K

Cash and Equivalents

N/A

EBITDA

INR 1.5B

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

INR 4.7B

Profit Margin

63.81%

52 Week High

INR 3.1K

52 Week Low

INR 1.7K

Dividend

0.84%

Price / Book Value

7.82

Price / Earnings

39.59

Price / Tangible Book Value

7.93

Enterprise Value

INR 44.8B

Enterprise Value / EBITDA

29.06

Operating Income

INR 1.3B

Return on Equity

N/A

Return on Assets

N/A

Cash and Short Term Investments

INR 2.7B

Debt

INR 200.0M

Equity

INR 6.1B

Revenue

INR 7.3B

Unlevered FCF

N/A

Sector

Pharmaceuticals

Category

N/A

Company Stock Pitches